Literature DB >> 1689104

Infantile hypophosphatasia: localization within chromosome region 1p36.1-34 and prenatal diagnosis using linked DNA markers.

C R Greenberg1, J A Evans, S McKendry-Smith, S Redekopp, J C Haworth, R Mulivor, B N Chodirker.   

Abstract

Linkage analysis was performed on data from Manitoba Mennonite families identified by a proband with infantile hypophosphatasia (HOPS), an autosomal recessive disorder characterized by defective skeletal mineralization. Southern blot analysis of Msp-I-digested DNA from HOPS nuclear families probed with a 2.55-kb liver/bone/kidney alkaline phosphatase (ALPL) cDNA revealed two previously undescribed RFLPs at 2.4/2.3 kb and 2.0/1.9 kb. Maximum combined lod score equals 13.25 at theta = 0. This establishes very close linkage between ALPL and HOPS and allows for the regional assignment of the HOPS gene to chromosome 1p36.1-34. Prenatal RFLP studies in an informative Mennonite family correctly predicted an unaffected fetus following chorionic villus sampling at 12 wk gestation. In addition in our Mennonite population, a nonrandom association exists between the polymorphic ALPL alleles and HOPS. These results suggest that strong linkage disequilibrium exists between HOPS and the ALPL markers. This will allow for improved carrier assignment in this high-risk population. Preliminary analysis suggests approximately 1/25 Manitoba Mennonites are HOPS carriers.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689104      PMCID: PMC1684978     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  16 in total

1.  Hypophosphatasia.

Authors:  D FRASER
Journal:  Am J Med       Date:  1957-05       Impact factor: 4.965

2.  Hypophosphatasia.

Authors:  R I Macpherson; M Kroeker; C S Houston
Journal:  J Can Assoc Radiol       Date:  1972-03

3.  Patterns of polymorphism and linkage disequilibrium for cystic fibrosis.

Authors:  X Estivill; P J Scambler; B J Wainwright; K Hawley; P Frederick; M Schwartz; M Baiget; J Kere; R Williamson; M Farrall
Journal:  Genomics       Date:  1987-11       Impact factor: 5.736

4.  Probe 8B/E5' detects a second RFLP at the human liver/bone/kidney alkaline phosphatase (ALPL) locus.

Authors:  K Ray; M J Weiss; N C Dracopoli; H Harris
Journal:  Nucleic Acids Res       Date:  1988-03-25       Impact factor: 16.971

5.  A high-frequency RFLP at the human liver/bone/kidney-type alkaline phosphatase locus.

Authors:  M J Weiss; R S Spielman; H Harris
Journal:  Nucleic Acids Res       Date:  1987-01-26       Impact factor: 16.971

6.  Infantile hypophosphatasia--linkage with the RH locus.

Authors:  B N Chodirker; J A Evans; M Lewis; G Coghlan; E Belcher; S Philipps; L E Seargeant; C Sus; C R Greenberg
Journal:  Genomics       Date:  1987-11       Impact factor: 5.736

7.  Analysis of liver/bone/kidney alkaline phosphatase mRNA, DNA, and enzymatic activity in cultured skin fibroblasts from 14 unrelated patients with severe hypophosphatasia.

Authors:  M J Weiss; K Ray; M D Fallon; M P Whyte; K N Fedde; M A Lafferty; R A Mulivor; H Harris
Journal:  Am J Hum Genet       Date:  1989-05       Impact factor: 11.025

8.  First trimester diagnosis of hypophosphatasia with a monoclonal antibody to the liver/bone/kidney isoenzyme of alkaline phosphatase.

Authors:  R C Warren; C F McKenzie; C H Rodeck; G Moscoso; D J Brock; L Barron
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

9.  DNA studies in a family with Duchenne muscular dystrophy and a deletion at Xp21.

Authors:  C R Greenberg; J L Hamerton; M Nigli; K Wrogemann
Journal:  Am J Hum Genet       Date:  1987-08       Impact factor: 11.025

10.  A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia.

Authors:  M J Weiss; D E Cole; K Ray; M P Whyte; M A Lafferty; R A Mulivor; H Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

View more
  20 in total

1.  Clinical utility gene card for: hypophosphatasia.

Authors:  Etienne Mornet; Christine Beck; Agnès Bloch-Zupan; Hermann Girschick; Martine Le Merrer
Journal:  Eur J Hum Genet       Date:  2010-10-27       Impact factor: 4.246

2.  Clinical utility gene card for: hypophosphatasia - update 2013.

Authors:  Etienne Mornet; Christine Hofmann; Agnès Bloch-Zupan; Hermann Girschick; Martine Le Merrer
Journal:  Eur J Hum Genet       Date:  2013-08-07       Impact factor: 4.246

3.  Skeletal mineralization defects in adult hypophosphatasia--a clinical and histological analysis.

Authors:  F Barvencik; F Timo Beil; M Gebauer; B Busse; T Koehne; S Seitz; J Zustin; P Pogoda; T Schinke; M Amling
Journal:  Osteoporos Int       Date:  2011-01-26       Impact factor: 4.507

4.  Outcome of perinatal hypophosphatasia in manitoba mennonites: a retrospective cohort analysis.

Authors:  Edward C W Leung; Aizeddin A Mhanni; Martin Reed; Michael P Whyte; Hal Landy; Cheryl R Greenberg
Journal:  JIMD Rep       Date:  2013-04-12

Review 5.  [Hypophosphatasia : What is currently available for treatment?]

Authors:  T Schmidt; M Amling; F Barvencik
Journal:  Internist (Berl)       Date:  2016-12       Impact factor: 0.743

6.  Glu274Lys/Gly309Arg mutation of the tissue-nonspecific alkaline phosphatase gene in neonatal hypophosphatasia associated with convulsions.

Authors:  O Reish; T Dolfin; S Arnon; R Regev; G Grinshpan; M Yamazaki; K Ozono
Journal:  J Inherit Metab Dis       Date:  2002-02       Impact factor: 4.982

7.  Adult-onset hypophosphatasia diagnosed following bilateral atypical femoral fractures in a 55-year-old woman.

Authors:  John E Lawrence; Danish Saeed; Jonathan Bartlett; Andrew D Carrothers
Journal:  Clin Cases Miner Bone Metab       Date:  2017-12-27

8.  Infantile hypophosphatasia secondary to a novel compound heterozygous mutation presenting with pyridoxine-responsive seizures.

Authors:  Dina Belachew; Traci Kazmerski; Ingrid Libman; Amy C Goldstein; Susan T Stevens; Stephanie Deward; Jerry Vockley; Mark A Sperling; Arcangela L Balest
Journal:  JIMD Rep       Date:  2013-03-12

9.  Reduced bone mineral density and low parathyroid hormone levels in patients with the adult form of hypophosphatasia.

Authors:  C Wüster; R Ziegler
Journal:  Clin Investig       Date:  1992-07

10.  Increased activity of TNAP compensates for reduced adenosine production and promotes ectopic calcification in the genetic disease ACDC.

Authors:  Hui Jin; Cynthia St Hilaire; Yuting Huang; Dan Yang; Natalia I Dmitrieva; Alejandra Negro; Robin Schwartzbeck; Yangtengyu Liu; Zhen Yu; Avram Walts; Jean-Michel Davaine; Duck-Yeon Lee; Danielle Donahue; Kevin S Hsu; Jessica Chen; Tao Cheng; William Gahl; Guibin Chen; Manfred Boehm
Journal:  Sci Signal       Date:  2016-12-13       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.